GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » C4X Discovery Holdings PLC (FRA:C4J) » Definitions » Quick Ratio

C4X Discovery Holdings (FRA:C4J) Quick Ratio : 15.30 (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is C4X Discovery Holdings Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. C4X Discovery Holdings's quick ratio for the quarter that ended in Jan. 2024 was 15.30.

C4X Discovery Holdings has a quick ratio of 15.30. It generally indicates good short-term financial strength.

The historical rank and industry rank for C4X Discovery Holdings's Quick Ratio or its related term are showing as below:

FRA:C4J' s Quick Ratio Range Over the Past 10 Years
Min: 3.28   Med: 7.49   Max: 29.64
Current: 15.31

During the past 12 years, C4X Discovery Holdings's highest Quick Ratio was 29.64. The lowest was 3.28. And the median was 7.49.

FRA:C4J's Quick Ratio is ranked better than
88.59% of 1542 companies
in the Biotechnology industry
Industry Median: 3.6 vs FRA:C4J: 15.31

C4X Discovery Holdings Quick Ratio Historical Data

The historical data trend for C4X Discovery Holdings's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C4X Discovery Holdings Quick Ratio Chart

C4X Discovery Holdings Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.30 5.81 10.59 5.34 3.28

C4X Discovery Holdings Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.81 5.34 7.24 3.28 15.30

Competitive Comparison of C4X Discovery Holdings's Quick Ratio

For the Biotechnology subindustry, C4X Discovery Holdings's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C4X Discovery Holdings's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, C4X Discovery Holdings's Quick Ratio distribution charts can be found below:

* The bar in red indicates where C4X Discovery Holdings's Quick Ratio falls into.



C4X Discovery Holdings Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

C4X Discovery Holdings's Quick Ratio for the fiscal year that ended in Jul. 2023 is calculated as

Quick Ratio (A: Jul. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(8.268-0)/2.522
=3.28

C4X Discovery Holdings's Quick Ratio for the quarter that ended in Jan. 2024 is calculated as

Quick Ratio (Q: Jan. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(28.818-0)/1.883
=15.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C4X Discovery Holdings  (FRA:C4J) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


C4X Discovery Holdings Quick Ratio Related Terms

Thank you for viewing the detailed overview of C4X Discovery Holdings's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


C4X Discovery Holdings (FRA:C4J) Business Description

Traded in Other Exchanges
Address
53 Portland Street, Manchester One, Manchester, GBR, M1 3LD
C4X Discovery Holdings PLC is a drug discovery and development company. It has various proprietary and synergistic software platforms Taxonomy3, Conformetrix, and 4Sight. Taxonomy3 is a novel in silico platform technology that utilizes proprietary ground-breaking mathematical algorithms to perform complex multivariate analysis of genetic data. Conformetrix enables rational, accelerated 4D structural drug design using experimental data rather than theoretical data. The 4Sight allows its research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules.

C4X Discovery Holdings (FRA:C4J) Headlines

No Headlines